SRPT logo

Sarepta Therapeutics, Inc. (SRPT) Net margin

annual net margin:

12.37%+55.48%(+128.69%)
December 31, 2024

Summary

  • As of today (September 9, 2025), SRPT annual net profit margin is 12.37%, with the most recent change of +55.48% (+128.69%) on December 31, 2024.
  • During the last 3 years, SRPT annual net margin has risen by +72.03% (+120.73%).
  • SRPT annual net margin is now at all-time high.

Performance

SRPT Net margin Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSRPTprofitability metrics

Quarterly net margin:

32.22%+92.30%(+153.63%)
June 30, 2025

Summary

  • As of today (September 9, 2025), SRPT quarterly net profit margin is 32.22%, with the most recent change of +92.30% (+153.63%) on June 30, 2025.
  • Over the past year, SRPT quarterly net margin has increased by +30.44% (+1710.11%).
  • SRPT quarterly net margin is now -55.08% below its all-time high of 71.72%, reached on June 30, 2012.

Performance

SRPT Quarterly net margin Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSRPTprofitability metrics

Net margin Formula

Net Margin =  Net Income
Revenue
✕ 100%

SRPT Net margin Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+128.7%+1710.1%
3 y3 years+120.7%+132.5%
5 y5 years+106.6%+129.3%

SRPT Net margin Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+116.4%at high+115.8%
5 y5-yearat high+106.6%at high+115.8%
alltimeall timeat high+100.0%-55.1%+100.0%

SRPT Net margin History

DateAnnualQuarterly
Jun 2025
-
32.22%(-153.6%)
Mar 2025
-
-60.08%(-348.7%)
Dec 2024
12.37%(-128.7%)
24.16%(+236.0%)
Sep 2024
-
7.19%(+303.9%)
Jun 2024
-
1.78%(-79.6%)
Mar 2024
-
8.74%(-24.1%)
Dec 2023
-43.11%(-42.8%)
11.51%(-193.3%)
Sep 2023
-
-12.34%(+34.7%)
Jun 2023
-
-9.16%(-95.5%)
Mar 2023
-
-203.85%(+382.3%)
Dec 2022
-75.40%(+26.4%)
-42.27%(-62.2%)
Sep 2022
-
-111.93%(+12.9%)
Jun 2022
-
-99.14%(+99.0%)
Mar 2022
-
-49.82%(-17.7%)
Dec 2021
-59.66%(-41.9%)
-60.55%(+138.2%)
Sep 2021
-
-25.42%(-48.8%)
Jun 2021
-
-49.61%(-56.4%)
Mar 2021
-
-113.83%(-12.7%)
Dec 2020
-102.60%(-45.4%)
-130.44%(-4.5%)
Sep 2020
-
-136.53%(+24.3%)
Jun 2020
-
-109.80%(+613.5%)
Mar 2020
-
-15.39%(-93.5%)
Dec 2019
-187.77%(+56.2%)
-235.44%(+84.6%)
Sep 2019
-
-127.55%(-56.3%)
Jun 2019
-
-291.97%(+231.5%)
Mar 2019
-
-88.08%(-47.2%)
Dec 2018
-120.23%(+266.7%)
-166.91%(+71.5%)
Sep 2018
-
-97.33%(-34.5%)
Jun 2018
-
-148.60%(+171.5%)
Mar 2018
-
-54.74%(+30.6%)
Dec 2017
-32.79%(-99.3%)
-41.90%(-59.7%)
Sep 2017
-
-103.87%(-42.3%)
Jun 2017
-
-180.07%(-89.0%)
Dec 2016
-4930.18%(-71.9%)
-1631.65%(-68.4%)
Dec 2015
-17.56K%(+1161.8%)
-5162.09%(-96.9%)
Dec 2014
-1391.71%(+76.7%)
-164.50K%(+5860.8%)
Sep 2014
-
-2759.77%(+110.4%)
Jun 2014
-
-1311.42%(+182.4%)
Mar 2014
-
-464.41%(+38.3%)
Dec 2013
-787.57%(+142.4%)
-335.87%(-66.7%)
Sep 2013
-
-1008.40%(+56.2%)
Jun 2013
-
-645.58%(-31.4%)
Mar 2013
-
-940.63%(+11.2%)
Dec 2012
-324.91%(+6490.5%)
-846.06%(+29.3%)
Sep 2012
-
-654.26%(-1012.2%)
Jun 2012
-
71.72%(-145.4%)
Mar 2012
-
-157.90%(+1421.2%)
Dec 2011
-4.93%(-95.5%)
-10.38%(-80.6%)
Sep 2011
-
-53.43%(-584.0%)
Jun 2011
-
11.04%(-13.9%)
Mar 2011
-
12.82%(-126.0%)
Dec 2010
-109.37%
-49.27%(-41.2%)
Sep 2010
-
-83.81%(-79.9%)
Jun 2010
-
-416.71%(+759.9%)
DateAnnualQuarterly
Mar 2010
-
-48.46%(-170.7%)
Dec 2009
-143.07%(+27.0%)
68.57%(-153.8%)
Sep 2009
-
-127.42%(-80.9%)
Jun 2009
-
-667.84%(+2169.2%)
Mar 2009
-
-29.43%(+41.4%)
Dec 2008
-112.68%(-54.4%)
-20.81%(-82.9%)
Sep 2008
-
-121.35%(+245.4%)
Jun 2008
-
-35.13%(-86.8%)
Mar 2008
-
-266.94%(+235.4%)
Dec 2007
-247.31%(-99.1%)
-79.58%(-67.1%)
Sep 2007
-
-241.63%(-33.4%)
Jun 2007
-
-363.04%(-80.0%)
Mar 2007
-
-1813.99%(-96.2%)
Dec 2006
-26.95K%(+7631.7%)
-47.60K%(+1.3%)
Sep 2006
-
-47.00K%(+26.7%)
Jun 2006
-
-37.11K%(+170.3%)
Mar 2006
-
-13.73K%(+4175.4%)
Dec 2005
-348.59%(-93.9%)
-321.12%(+522.7%)
Sep 2005
-
-51.57%(-99.6%)
Jun 2005
-
-12.55K%(+3.2%)
Mar 2005
-
-12.17K%(+596.3%)
Dec 2004
-5756.08%(+281.9%)
-1747.30%(-96.9%)
Sep 2004
-
-55.51K%(+181.9%)
Jun 2004
-
-19.69K%(+160.1%)
Mar 2004
-
-7570.35%(+230.6%)
Dec 2003
-1507.08%(-57.0%)
-2290.09%(+106.1%)
Sep 2003
-
-1110.93%(-48.4%)
Jun 2003
-
-2153.88%(+62.5%)
Mar 2003
-
-1325.63%(-43.8%)
Dec 2002
-3508.56%(-8.0%)
-2360.40%(-22.3%)
Sep 2002
-
-3039.22%(-42.7%)
Jun 2002
-
-5302.02%(+61.2%)
Mar 2002
-
-3288.22%(+110.9%)
Dec 2001
-3813.21%(+435.4%)
-1559.19%(-69.2%)
Sep 2001
-
-5063.64%(+24.7%)
Jun 2001
-
-4061.86%(-79.6%)
Mar 2001
-
-19.87K%(+65.1%)
Dec 2000
-712.22%(-91.4%)
-12.03K%(+552.8%)
Sep 2000
-
-1842.96%(-88.2%)
Jun 2000
-
-15.61K%(>+9900.0%)
Mar 2000
-
-100.71%(-99.8%)
Dec 1999
-8300.00%(-68.9%)
-
Sep 1999
-
-61.25K%(-96.9%)
Jun 1999
-
-2.00M%(+4607.4%)
Mar 1999
-
-42.43K%(-90.0%)
Dec 1998
-26.70K%(+641.7%)
-
Sep 1998
-
-425.16K%(+1488.4%)
Jun 1998
-
-26.77K%(+5.2%)
Mar 1998
-
-25.44K%(+2727.2%)
Dec 1997
-3600.00%(+71.4%)
-
Sep 1997
-
-900.00%(-30.8%)
Jun 1997
-
-1300.00%(+333.3%)
Mar 1997
-
-300.00%
Dec 1996
-2100.00%
-

FAQ

  • What is Sarepta Therapeutics, Inc. annual net profit margin?
  • What is the all time high annual net margin for Sarepta Therapeutics, Inc.?
  • What is Sarepta Therapeutics, Inc. annual net margin year-on-year change?
  • What is Sarepta Therapeutics, Inc. quarterly net profit margin?
  • What is the all time high quarterly net margin for Sarepta Therapeutics, Inc.?
  • What is Sarepta Therapeutics, Inc. quarterly net margin year-on-year change?

What is Sarepta Therapeutics, Inc. annual net profit margin?

The current annual net margin of SRPT is 12.37%

What is the all time high annual net margin for Sarepta Therapeutics, Inc.?

Sarepta Therapeutics, Inc. all-time high annual net profit margin is 12.37%

What is Sarepta Therapeutics, Inc. annual net margin year-on-year change?

Over the past year, SRPT annual net profit margin has changed by +55.48% (+128.69%)

What is Sarepta Therapeutics, Inc. quarterly net profit margin?

The current quarterly net margin of SRPT is 32.22%

What is the all time high quarterly net margin for Sarepta Therapeutics, Inc.?

Sarepta Therapeutics, Inc. all-time high quarterly net profit margin is 71.72%

What is Sarepta Therapeutics, Inc. quarterly net margin year-on-year change?

Over the past year, SRPT quarterly net profit margin has changed by +30.44% (+1710.11%)
On this page